mbia Business School, Rockefeller University, others. Fmr Chair, Partnership for New York City. Marie-Josee Kravis — Boards: Publicis, LVMH. Boards: Memorial Sloan-Kettering Cancer Center, Robin Hood Foundation, Council on Foreign Relations, Qatar Museum Authority. President, Museum of Modern Art board of directors. Fmr Board: Ford, IA

ancer How “exceptionalresponders’ ‘arerevolutionizing treatment for the deadly desease BY KAT MCGOWAN UST LIKE EVERY NEW drug the oncologists at Memorial Sloan-Kettering Cancer Center test- ed against bladder cancer in the last 20 years, this one didn’t seem to be doing any good. For- ty-four people in the study were given everolim

ylvania School of Medicine in 1991. Agus completed his residency training at Johns Hopkins Hospital and completed his oncology fellowship training at the Memorial Sloan-Kettering Cancer Center in New York. He spent two years at the National Institutes of Health as a Howard Hughes Medical Institute-NIH Research Scholar. Agus has had a long

bia Business School, Rockefeller University, others. Fmr Chair, Partnership for New York City. *Marie-Josee Kravis*— Boards: Publicis, LVMH. Boards: Memorial Sloan-Kettering Cancer Center, Robin Hood Foundation, Council on Foreign Relations, Qatar Museum Authority. President, Museum of Modern Art board of directors. Fmr Board: Ford, I